Taken together, these findings demonstrate that E2F1 promotes HCC cell proliferation and invasion through enhancing DDX11 expression, which involves the PI3K/Akt/mTOR signaling pathway (Fig. 8g). Here, MTOR is linked to hepatocellular carcinoma.